Narendranath Epperla

The Ohio State University Comprehensive Cancer Center

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (11)

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (8)

Leslie Andritsos

Professor

University of New Mexico

UNITED STATES

View details

John Reneau

Ohio State University

UNITED STATES

View details

Natalie Grover

Assistant Professor

University of North Carolina at Chapel Hill School of Medicine

UNITED STATES

View details

Lapo Alinari

Ohio State University

UNITED STATES

View details

XIAOLI ZHANG

Assistant Professor

Ohio State University

UNITED STATES

View details

Yazeed Sawalha

The Ohio State University Comprehensive Cancer Center

UNITED STATES

View details

Clive Zent

Professor

University of Rochester

UNITED STATES

View details

Timothy Voorhees

Assistant Professor - Clinical

The Ohio State University Wexner Medical Center

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Narendranath Epperla

Research Interests

Explore related searches

Contact this professor

Articles (11)

A Phase 2 Trial of Ibrutinib and Nivolumab in Patients with Relapsed or Refractory Classical Hodgkin’s Lymphoma

Impact of circulating lymphoma cells at diagnosis on outcomes in patients with marginal zone lymphoma: a multicenter cohort study

Autologous hematopoietic cell transplantation versus whole-brain radiotherapy consolidation in primary central nervous system lymphoma: A systematic review and meta-analysis

Development of a distributed international patient data registry for hairy cell leukemia

Identifying aggressive subsets within diffuse large B-cell lymphoma: implications for treatment approach

An international analysis evaluating frontline bendamustine with rituximab in extranodal marginal zone lymphoma

CENTRAL NERVOUS SYSTEM INTRAVASCULAR LARGE B CELL LYMPHOMA: IS THERE A BEST APPROACH?

Consensus opinion from an international group of experts on measurable residual disease in hairy cell leukemia

Editorial: Rising Stars in Hematologic Malignancies 2021

Feasibility of high-dose methotrexate administered on day 1 of (R)CHOP in aggressive non-Hodgkin lymphomas

Collaborators (8)

Leslie Andritsos

John Reneau

Natalie Grover

Lapo Alinari

XIAOLI ZHANG

Yazeed Sawalha

Clive Zent

Timothy Voorhees

Make your next move.